New York Times Top Stories
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
The deal is a bet on the growing market for psychiatric and neurological drugs.
New York Times Top StoriesNew York Times Top StoriesNew York Times Top StoriesThe deal is a bet on the growing market for psychiatric and neurological drugs.